Intestinal biopsy is not always required to diagnose celiac disease: a retrospective analysis of combined antibody tests
Open Access
- 23 January 2013
- journal article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 13 (1) , 19
Abstract
Background: The objective of this study was to compare celiac disease (CD)– specific antibody tests to determine if they could replace jejunal biopsy in patients with a high pretest probability of CD. Methods: This retrospective study included sera from 149 CD patients and 119 controls, all with intestinal biopsy. All samples were analyzed for IgA and IgG antibodies against native gliadin (ngli) and deamidated gliadin peptides (dpgli), as well as for IgA antibodies against tissue transglutaminase and endomysium. Results: Tests for dpgli were superior to ngli for IgG antibody determination: 68% vs. 92% specificity and 79% vs. 85% sensitivity for ngli and dpgli, respectively. Positive (76% vs. 93%) and negative (72% vs. 83%) predictive values were also higher for dpgli than for ngli. Regarding IgA gliadin antibody determination, sensitivity improved from 61% to 78% with dpgli, while specificity and positive predictive value remained at 97% (P < 0.00001). A combination of four tests (IgA anti-dpgli, IgG anti-dpgli, IgA anti- tissue transglutaminase, and IgA anti-endomysium) yielded positive and negative predictive values of 99% and 100%, respectively and a likelihood ratio positive of 86 with a likelihood ratio negative of 0.00. Omitting the endomysium antibody determination still yielded positive and negative predictive values of 99% and 98%, respectively and a likelihood ratio positive of 87 with a likelihood ratio negative of 0.01. Conclusion: Antibody tests for dpgli yielded superior results compared with ngli. A combination of three or four antibody tests including IgA anti-tissue transglutaminase and/or IgA anti- endomysium permitted diagnosis or exclusion of CD without intestinal biopsy in a high proportion of patients (78%). Jejunal biopsy would be necessary in patients with discordant antibody results (22%). With this two-step procedure, only patients with no CD-specific antibodies would be missed.Keywords
This publication has 41 references indexed in Scilit:
- European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the Diagnosis of Coeliac DiseaseJournal of Pediatric Gastroenterology and Nutrition, 2012
- Celiac Disease Diagnosis: Simple Rules Are Better Than Complicated AlgorithmsThe American Journal of Medicine, 2010
- Increasing prevalence and high incidence of celiac disease in elderly people: A population-based studyBMC Gastroenterology, 2009
- Diagnosing Mild Enteropathy Celiac Disease: A Randomized, Controlled Clinical StudyGastroenterology, 2009
- Comparative Usefulness of Deamidated Gliadin Antibodies in the Diagnosis of Celiac DiseaseClinical Gastroenterology and Hepatology, 2008
- Coeliac disease: a biopsy is not always necessary for diagnosisAlimentary Pharmacology & Therapeutics, 2008
- Usefulness of Antibodies to Deamidated Gliadin Peptides in Celiac Disease Diagnosis and Follow-upDigestive Diseases and Sciences, 2007
- Latent coeliac disease or coeliac disease beyond villous atrophy?Gut, 2007
- The Absence of a Mucosal Lesion on Standard Histological Examination Does Not Exclude Diagnosis of Celiac DiseaseDigestive Diseases and Sciences, 2007
- Coeliac disease: an update for pathologistsJournal of Clinical Pathology, 2006